1. Home
  2. INVZ vs MIST Comparison

INVZ vs MIST Comparison

Compare INVZ & MIST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INVZ
  • MIST
  • Stock Information
  • Founded
  • INVZ 2016
  • MIST 2003
  • Country
  • INVZ Israel
  • MIST Canada
  • Employees
  • INVZ N/A
  • MIST 33
  • Industry
  • INVZ Auto Parts:O.E.M.
  • MIST Biotechnology: Pharmaceutical Preparations
  • Sector
  • INVZ Consumer Discretionary
  • MIST Health Care
  • Exchange
  • INVZ Nasdaq
  • MIST Nasdaq
  • Market Cap
  • INVZ 186.3M
  • MIST 132.5M
  • IPO Year
  • INVZ N/A
  • MIST N/A
  • Fundamental
  • Price
  • INVZ $1.90
  • MIST $1.60
  • Analyst Decision
  • INVZ Strong Buy
  • MIST Strong Buy
  • Analyst Count
  • INVZ 5
  • MIST 2
  • Target Price
  • INVZ $3.38
  • MIST $7.50
  • AVG Volume (30 Days)
  • INVZ 10.4M
  • MIST 2.6M
  • Earning Date
  • INVZ 08-06-2025
  • MIST 08-07-2025
  • Dividend Yield
  • INVZ N/A
  • MIST N/A
  • EPS Growth
  • INVZ N/A
  • MIST N/A
  • EPS
  • INVZ N/A
  • MIST N/A
  • Revenue
  • INVZ $34,601,000.00
  • MIST N/A
  • Revenue This Year
  • INVZ $137.25
  • MIST N/A
  • Revenue Next Year
  • INVZ $128.53
  • MIST N/A
  • P/E Ratio
  • INVZ N/A
  • MIST N/A
  • Revenue Growth
  • INVZ 28.52
  • MIST N/A
  • 52 Week Low
  • INVZ $0.45
  • MIST $0.63
  • 52 Week High
  • INVZ $3.14
  • MIST $2.75
  • Technical
  • Relative Strength Index (RSI)
  • INVZ 68.70
  • MIST 46.03
  • Support Level
  • INVZ $1.56
  • MIST $1.36
  • Resistance Level
  • INVZ $1.75
  • MIST $1.73
  • Average True Range (ATR)
  • INVZ 0.13
  • MIST 0.18
  • MACD
  • INVZ 0.00
  • MIST -0.07
  • Stochastic Oscillator
  • INVZ 91.69
  • MIST 23.75

About INVZ Innoviz Technologies Ltd. Ordinary shares

Innoviz Technologies Ltd is a provider of solid-state LiDAR and perception solutions that feature technological breakthroughs across core components and bring enhanced vision and superior performance to enable safe autonomous driving at a mass scale. The company provides a complete and comprehensive solution for OEMs and Tier-1 partners that are developing and marketing autonomous driving vehicles to the passenger cars and other relevant markets, such as robotaxis, shuttles, delivery vehicles, buses and trucks and other industries that require 3-dimensional high resolution sensors. Company's solutions can enable safe autonomy for industries like logistics, drones, robotics, construction and other industrial applications, agriculture, smart city, smart infrastructure, security and mapping.

About MIST Milestone Pharmaceuticals Inc.

Milestone Pharmaceuticals Inc is a biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular medicines. Etripamil is a calcium channel blocker developed as a rapid-onset nasal spray to be administered by the patient to treat episodes of paroxysmal supraventricular tachycardia, or PSVT. The company has an ongoing Phase 2 clinical trial for patients with atrial fibrillation experiencing a rapid ventricular rate (AFib-RVR).

Share on Social Networks: